Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1998 Jun;82(6):661–665. doi: 10.1136/bjo.82.6.661

Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium

J C Sanchez-Thorin 1, G Rocha 1, J Yelin 1
PMCID: PMC1722618  PMID: 9797669

Abstract

BACKGROUND/AIMS—Bare sclera resection with and without use of mitomycin C and conjunctival autograft placement are three surgical techniques currently in use for the treatment of primary pterygium. The purpose of this study was to determine through a meta-analysis the risk for postoperative pterygium recurrence comparing the three surgical treatment modalities.
METHODS—A search through Medline for randomised controlled clinical trials comparing at least two of the three surgical techniques in the treatment of primary pterygium, along with a hand search of all references in relevant papers, was conducted. All eligible clinical trials were graded for quality utilising the Detsky score; those studies with a score of 0.5 or greater were included. The main outcome measurements were the pooled odds ratios and 95% confidence intervals for the risk of pterygium recurrence. These were calculated utilising the Mantel-Haenszel method.
RESULTS—Five eligible studies with an adequate quality score were retrieved, three comparing bare sclera resection with and without mitomycin C use, one comparing bare sclera resection with conjunctival autograft placement, and one comparing both. The pooled odds ratio for pterygium recurrence in patients who had only bare sclera resection was 6.1 (95% confidence intervals, 1.8 to 18.8) compared with the patients who had conjunctival autograft placement and 25.4 (9.0 to 66.7) compared with the patients who received mitomycin C.
CONCLUSIONS—The odds for pterygium recurrence following surgical treatment of primary pterygium are close to six and 25 times higher if no conjunctival autograft placement is performed or if no intra/postoperative mitomycin C is used, respectively. Surgeons and clinical triallists should not be encouraged in the use of bare sclera resection as a surgical technique for primary pterygium.

 Keywords: meta-analysis; bare sclera resection; pterygium; mitomycin C

Full Text

The Full Text of this article is available as a PDF (100.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Individual study and pooled odds ratios and 95% confidence intervals calculated from data provided by original studies comparing bare sclera resection with postoperative mitomycin C versus placebo. Singh et al 23 OR: 109.33 (12.18-980.34), Frucht-Pery et al 24 OR: 25.38 (4.68-136.4), Cano-Parra et al 15 OR: 18.45 (2.24-150.27), Chen et al 11 OR: 12.5 (0.81-192.92). (OR = individual study odds ratio, 95% confidence intervals for individual studies are in parenthesis.) Cumulative odds ratio: 25.4 (95% cumulative confidence intervals 9.02 to 66.69)

Figure 2  .

Figure 2  

Open in a new tab

Individual study and pooled odds ratios and 95% confidence intervals calculated from data provided by original studies comparing bare sclera resection versus conjunctival autograft placement. Lewallen et al 14 OR: 3.11 (0.17-55.21), Chen et al 11 OR:11.67 (2.14-64.04). (OR = individual study odds ratio, 95% confidence intervals for individual studies are in parenthesis.) Cumulative odds ratio: 6.1 (95% cumulative confidence intervals 1.82-18.75).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cano-Parra J., Diaz-Llopis M., Maldonado M. J., Vila E., Menezo J. L. Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium. Br J Ophthalmol. 1995 May;79(5):439–441. doi: 10.1136/bjo.79.5.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chayakul V. Postoperative mitomycin-C eye drop and beta radiation in the treatment of pterygia. J Med Assoc Thai. 1991 Sep;74(9):373–376. [PubMed] [Google Scholar]
  3. Chen P. P., Ariyasu R. G., Kaza V., LaBree L. D., McDonnell P. J. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium. Am J Ophthalmol. 1995 Aug;120(2):151–160. doi: 10.1016/s0002-9394(14)72602-9. [DOI] [PubMed] [Google Scholar]
  4. D'Ombrain A. THE SURGICAL TREATMENT OF PTERYGIUM. Br J Ophthalmol. 1948 Feb;32(2):65–71. doi: 10.1136/bjo.32.2.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Detsky A. S., Naylor C. D., O'Rourke K., McGeer A. J., L'Abbé K. A. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992 Mar;45(3):255–265. doi: 10.1016/0895-4356(92)90085-2. [DOI] [PubMed] [Google Scholar]
  6. Dickersin K., Hewitt P., Mutch L., Chalmers I., Chalmers T. C. Perusing the literature: comparison of MEDLINE searching with a perinatal trials database. Control Clin Trials. 1985 Dec;6(4):306–317. doi: 10.1016/0197-2456(85)90106-0. [DOI] [PubMed] [Google Scholar]
  7. Dowlut M. S., Laflamme M. Y. Les ptérygions récidivants: fréquence et correction par autogreffe conjonctivale. Can J Ophthalmol. 1981 Jul;16(3):119–120. [PubMed] [Google Scholar]
  8. Frucht-Pery J., Ilsar M., Hemo I. Single dosage of mitomycin C for prevention of recurrent pterygium: preliminary report. Cornea. 1994 Sep;13(5):411–413. doi: 10.1097/00003226-199409000-00006. [DOI] [PubMed] [Google Scholar]
  9. Güler M., Sobaci G., Ilker S., Oztürk F., Mutlu F. M., Yildirim E. Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol (Copenh) 1994 Dec;72(6):721–726. doi: 10.1111/j.1755-3768.1994.tb04688.x. [DOI] [PubMed] [Google Scholar]
  10. Hayasaka S., Noda S., Yamamoto Y., Setogawa T. Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol. 1988 Dec 15;106(6):715–718. doi: 10.1016/0002-9394(88)90706-4. [DOI] [PubMed] [Google Scholar]
  11. Jaros P. A., DeLuise V. P. Pingueculae and pterygia. Surv Ophthalmol. 1988 Jul-Aug;33(1):41–49. doi: 10.1016/0039-6257(88)90071-9. [DOI] [PubMed] [Google Scholar]
  12. Kenyon K. R., Wagoner M. D., Hettinger M. E. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985 Nov;92(11):1461–1470. doi: 10.1016/s0161-6420(85)33831-9. [DOI] [PubMed] [Google Scholar]
  13. Lewallen S. A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology. 1989 Nov;96(11):1612–1614. doi: 10.1016/s0161-6420(89)32667-4. [DOI] [PubMed] [Google Scholar]
  14. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  15. Mahar P. S., Nwokora G. E. Role of mitomycin C in pterygium surgery. Br J Ophthalmol. 1993 Jul;77(7):433–435. doi: 10.1136/bjo.77.7.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Poynard T., Conn H. O. The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods. Control Clin Trials. 1985 Dec;6(4):271–279. doi: 10.1016/0197-2456(85)90103-5. [DOI] [PubMed] [Google Scholar]
  17. Riordan-Eva P., Kielhorn I., Ficker L. A., Steele A. D., Kirkness C. M. Conjunctival autografting in the surgical management of pterygium. Eye (Lond) 1993;7(Pt 5):634–638. doi: 10.1038/eye.1993.146. [DOI] [PubMed] [Google Scholar]
  18. Rubinfeld R. S., Pfister R. R., Stein R. M., Foster C. S., Martin N. F., Stoleru S., Talley A. R., Speaker M. G. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992 Nov;99(11):1647–1654. doi: 10.1016/s0161-6420(92)31749-x. [DOI] [PubMed] [Google Scholar]
  19. Said A., Fouad A. R., Mostafa M. S., Abbas S. Surgical management of recurrent pterygium by an operation of transposition. Bull Ophthalmol Soc Egypt. 1975;68:81–84. [PubMed] [Google Scholar]
  20. Schrage N. F., Kuckelkorn R., Joisten M., Reim M. Operative Therapie des Pterygiums. Rezidivquote nach freiem Bindehauttransplantat und nach Operationstechniken ohne Transplantation. Ophthalmologe. 1993 Dec;90(6):691–693. [PubMed] [Google Scholar]
  21. Sebban A., Hirst L. W. Pterygium recurrence rate at the Princess Alexandra Hospital. Aust N Z J Ophthalmol. 1991 Aug;19(3):203–206. doi: 10.1111/j.1442-9071.1991.tb00661.x. [DOI] [PubMed] [Google Scholar]
  22. Sebban A., Hirst L. W. Treatment of pterygia in Queensland. Aust N Z J Ophthalmol. 1991 May;19(2):123–127. doi: 10.1111/j.1442-9071.1991.tb00639.x. [DOI] [PubMed] [Google Scholar]
  23. Singh G., Wilson M. R., Foster C. S. Long-term follow-up study of mitomycin eye drops as adjunctive treatment of pterygia and its comparison with conjunctival autograft transplantation. Cornea. 1990 Oct;9(4):331–334. [PubMed] [Google Scholar]
  24. Singh G., Wilson M. R., Foster C. S. Mitomycin eye drops as treatment for pterygium. Ophthalmology. 1988 Jun;95(6):813–821. doi: 10.1016/s0161-6420(88)33104-0. [DOI] [PubMed] [Google Scholar]
  25. Starck T., Kenyon K. R., Serrano F. Conjunctival autograft for primary and recurrent pterygia: surgical technique and problem management. Cornea. 1991 May;10(3):196–202. doi: 10.1097/00003226-199105000-00002. [DOI] [PubMed] [Google Scholar]
  26. de Keizer R. J. Pterygium excision with or without postoperative irradiation, a double-blind study. Doc Ophthalmol. 1982 Jan 29;52(3-4):309–315. doi: 10.1007/BF01675860. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES